The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Self-Monitoring of RA Treatment May Lead to Fewer Office Visits

Self-Monitoring of RA Treatment May Lead to Fewer Office Visits

September 5, 2015 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Self-monitoring of methotrexate therapy may curb healthcare utilization in rheumatoid arthritis (RA) and psoriatic arthritis, according to a new trial.

You Might Also Like
  • Healthcare Software Makes Office Visits More Productive for Patients, Physicians
  • Arthritis Power App Can Help Patients Monitor Symptoms, Improve Office Visits
  • New Patient vs. Established Patient Office Visits

The study indicates “that this novel model of care led to significant reductions in outpatient visits to the (clinical nurse specialist) and a reduction in visits to the GP, while maintaining the regularity with which patients saw their rheumatologist,” researchers report in Annals of the Rheumatic Diseases, online Aug. 19.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Treatment of arthritis has become increasingly complex, necessitating intensive monitoring and frequent follow-up visits, Dr. Stanton Newman of the School of Health Sciences in London and colleagues noted in their report.

The team sought to determine if patient self-monitoring of symptoms and blood tests while being treated with disease-modifying antirheumatic drugs (DMARDs) would cut the number of clinic visits.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The study was a single-center, randomized controlled trial involving 100 patients on a stable dose of methotrexate for either psoriatic arthritis or RA. Each participant received training on laboratory result interpretation and when to notify their designated clinical nurse specialist (CNS).

The control group received standard follow-up care with laboratory tests every four to six weeks, rheumatologist appointment every six months, and nurse visits every three months. All laboratory studies were independently reviewed by the nurse and researcher for safety purposes.

Patients who self-monitored had fewer visits to the clinical nurse specialist (30 vs. 66, p<0.0001) and to the general practitioner (29 vs. 47, p=0.07), but nearly as many visits to the rheumatologist (96 vs. 103, p=0.23).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

They also showed improvement in the ability to appropriately initiate care (from 65.4% of all decisions to 89.1% over six weeks).

There were no significant differences in response to treatment (p=0.77) or levels of fatigue, pain, disability, or psychosocial factors between the two groups.

In the intervention group, two participants were unable to safely and accurately interpret the laboratory results and initiate care and thus were returned to standard care. Therefore, the authors note that a pilot phase of the self-monitoring program may be needed for each patient.

“It is reassuring that an intervention that required patients to pay closer attention to their illness and reduced unnecessary healthcare visits did not have a detrimental impact on patients’ psychosocial well-being,” the researchers write.

Dr. Newman did not respond for comment.

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: disease-modifying antirheumatic drugs, Methotrexate, patient, patient management, Rheumatiod arthritis

You Might Also Like:
  • Healthcare Software Makes Office Visits More Productive for Patients, Physicians
  • Arthritis Power App Can Help Patients Monitor Symptoms, Improve Office Visits
  • New Patient vs. Established Patient Office Visits
  • Verify Patients’ Insurance Eligibility, Coverage Before Office Visits

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)